These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 31775482
1. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia]. Dao FT, Yang L, Wang YZ, Chang Y, Jiang Q, Jiang H, Liu YR, Huang XJ, Qin YZ. Zhonghua Xue Ye Xue Za Zhi; 2019 Oct 14; 40(10):831-836. PubMed ID: 31775482 [Abstract] [Full Text] [Related]
2. Expressions of CD96 and CD123 in Bone Marrow Cells of Patients with Myelodysplastic Syndromes. Zhang W, Shao Z, Fu R, Wang H, Li L, Liu H. Clin Lab; 2015 Oct 14; 61(10):1429-34. PubMed ID: 26642704 [Abstract] [Full Text] [Related]
3. [Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia]. Yao DD, Han BQ, Han YF, Zhang YQ, Jin YL, Dai HB. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec 14; 26(6):1583-1588. PubMed ID: 30501688 [Abstract] [Full Text] [Related]
4. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia. Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H. Arch Med Res; 2014 May 14; 45(4):343-50. PubMed ID: 24751333 [Abstract] [Full Text] [Related]
5. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A, Gillis D, Lewis I. J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508 [Abstract] [Full Text] [Related]
10. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML. Li LJ, Tao JL, Fu R, Wang HQ, Jiang HJ, Yue LZ, Zhang W, Liu H, Shao ZH. Int J Hematol; 2014 Jul 27; 100(1):60-9. PubMed ID: 24846193 [Abstract] [Full Text] [Related]
11. Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells. Jaddaoui S, Bencharef H, Lamchahab M, Quessar A, Oukkache B. Clin Lab; 2022 Jun 01; 68(6):. PubMed ID: 35704721 [Abstract] [Full Text] [Related]
16. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. Herrmann H, Sadovnik I, Eisenwort G, Rülicke T, Blatt K, Herndlhofer S, Willmann M, Stefanzl G, Baumgartner S, Greiner G, Schulenburg A, Mueller N, Rabitsch W, Bilban M, Hoermann G, Streubel B, Vallera DA, Sperr WR, Valent P. Blood Adv; 2020 Oct 27; 4(20):5118-5132. PubMed ID: 33085758 [Abstract] [Full Text] [Related]
17. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia. Wang J, Yang L, Dao FT, Wang YZ, Chang Y, Xu N, Chen WM, Jiang Q, Jiang H, Liu YR, Qin YZ. Leuk Lymphoma; 2022 Jan 27; 63(1):152-161. PubMed ID: 34405769 [Abstract] [Full Text] [Related]
18. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia. Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M. Pediatr Hematol Oncol; 2011 Mar 27; 28(2):91-9. PubMed ID: 21214408 [Abstract] [Full Text] [Related]
19. CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia. Heo SK, Noh EK, Ju LJ, Sung JY, Jeong YK, Cheon J, Koh SJ, Min YJ, Choi Y, Jo JC. BMC Cancer; 2020 Apr 06; 20(1):285. PubMed ID: 32252668 [Abstract] [Full Text] [Related]